Riskpilot← Back to searchSign inGet full accessFulgurite AB
ABActiveOrg 5593176927Enskedevägen 98 AResearch and experimental development on natural sciences and engineering · NACE 7210Est. 20210 employees
Revenue 2024
SEK 2,3M
+1128% vs 2023
EBITDA margin
55.1%
+5185% vs 2023
Equity ratio
59.9%
Financial strength
Net profit 2024
SEK 756K
+49992% vs 2023
| Revenue | SEK 2,3M | +1128% |
| EBITDA | SEK 1,3M | +5185% |
| Net profit | SEK 756K | +49992% |
| Total assets | SEK 2,1M | +176% |
| Equity | SEK 1,3M | +151% |
| Employees | 0 | — |
Legal name
Fulgurite AB
Org number
5593176927
Legal form
Aktiebolag
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
17 maj 2021
Share capital
SEK 25 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Med fokus på utveckling av terapeutiska läkemedel och människors hälsa arbetar företaget med läkemedelsbehandlingar och diagnostiska verktyg för prekliniskt stadium. Övergång av akademiska vetenskapliga principer mot industriella miljöer med tonvikt på att utveckla biologiska handlingssätt, kandidatläkemedelsnominering, utredningsdokumentation för nya läkemedel, läkemedelsprofilering och kliniska prövningar i tidig fas. Företaget erbjuder konsulttjänster till akademiker, branschpersonal och företag inom området, medicinska vetenskaper och farmakologi.
Address
Enskedevägen 98 A
Email
stafford@fulgurite.eu
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Revenue | 1 029 | 1 101 | 189 | 2 326 |
| Staff expenses | — | −487 | −118 | −809 |
| EBITDA | 264 | 526 | −25 | 1 282 |
| Depreciation & amort. | −0 | — | — | — |
| EBIT | 264 | 526 | −25 | 1 282 |
| Net financials | — | 6 | −0 | −1 |
| Profit before tax | 198 | 399 | 5 | 957 |
| Tax | −41 | −82 | −3 | −201 |
| Net profit | 157 | 316 | 2 | 756 |
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Total assets | 400 | 869 | 759 | 2 096 |
| Equity | 182 | 498 | 500 | 1 256 |
| Long-term debt | 0 | — | — | — |
| Short-term debt | 152 | 172 | 90 | 348 |
| Total debt | 152 | 172 | 90 | 348 |
EBITDA margin
55.1%
This company
15.8%
Market median
+249% vs market
20212024
Equity ratio
59.9%
This company
38.2%
Market median
+57% vs market
20212024
Return on equity
60.2%
This company
18.4%
Market median
+227% vs market
20212024
Net profit margin
32.5%
This company
8.1%
Market median
+301% vs market
20212024
Asset turnover
1.11×
This company
1.12×
Market median
+1% vs market
20212024
Debt / equity
0.67×
This company
0.62×
Market median
+8% vs market
20212024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-05-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
WC Chief Executive Officer | Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Fulgurite AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| William Chester Stafford | Chief Executive Officer | 0 companies |
| Per Allan Hüttner | Deputy Board Member | 0 companies |
| Per Allan Hüttner | Deputy Board Member | 0 companies |